Print

New ANDA Cases

Case Name Date Filed Judge Drug Patent No(s).
Forest Labs., LLC v. Apotex Corp., 15-
0018 (D. Del.)
Jan. 5, 2015 Hon. Gregory M. Sleet Teflaro® (ceftaroline fosamil injection for intravenous)
6,417,175
6,906,055
7,419,973
8,247,400
Praxair Distribution, Inc. v. iNO Therapeutics, Inc., IPR2015-00522 (PTAB) Jan. 5, 2015 N/A INOmax® (nitric oxide) 8,282,966
Praxair Distribution, Inc. v. iNO Therapeutics, Inc., IPR2015-00524 (PTAB) Jan. 5, 2015 N/A INOmax ® (nitric oxide) 8,293,284
Praxair Distribution, Inc. v. iNO Therapeutics, Inc., IPR2015-00525 (PTAB) Jan. 5, 2015 N/A INOmax ® (nitric oxide) 8,431,163
Praxair Distribution, Inc. v. iNO Therapeutics, Inc., IPR2015-00526 (PTAB) Jan. 5, 2015 N/A INOmax ® (nitric oxide) 8,795,741
Praxair Distribution, Inc. v. iNO Therapeutics, Inc., IPR2015-00529 (PTAB) Jan. 5, 2015 N/A INOmax ® (nitric oxide) 8,846,112
Iceutica Pty Ltd. v. Lupin Ltd., 15-0045 (D. Md.) Jan. 7, 2015 Hon. J. Frederick Motz Zorvolex® (diclofenac capsules) 8,679,544
Sanofi-Aventis U.S. LLC v. Accord Healthcare, Inc., 15-0018 (M.D.N.C.) Jan. 7, 2015 Hon. N. C. Tilley, Jr. Jevtana® Kit (cabazitaxel injection) 5,847,170
Pfizer Inc. v. Mylan Inc., 15-0026 (D. Del.) Jan. 8, 2015 Hon. Sue L. Robinson Tygacil® (tigecycline injectable IV infusion)
7,879,828
8,372,995
Salix Pharms., Inc. v. Novel Labs., Inc., 15-0027 (D. Del.) Jan. 8, 2015 Hon. Gregory M. Sleet Apriso® (mesalamine capsules) 8,865,688
Otsuka Pharm. Co., Ltd. v. Hetero Drugs Ltd., 15-0161 (D.N.J.) Jan. 8, 2015 Hon. Jerome B. Simandle Abilify® (aripiprazole tablets)
8,580,796
8,642,760
8,759,350
Jazz Pharms., Inc. v. Par Pharm, Inc., 15-0173 (D.N.J.) Jan. 8, 2015 Hon. Esther Salas Xyrem® (sodium oxybate oral solution) 8,859,619
Amneal Pharms. LLC v. Jazz Pharms., Inc., IPR2015-00545 (PTAB) Jan. 8, 2015 N/A Xyrem® (sodium oxybate oral solution) 8,589,182
Amneal Pharms. LLC v. Jazz Pharms., Inc., IPR2015-00546 (PTAB) Jan. 8, 2015 N/A Xyrem® (sodium oxybate oral solution) 7,765,106
Amneal Pharms. LLC v. Jazz Pharms., Inc., IPR2015-00547 (PTAB) Jan. 8, 2015 N/A Xyrem® (sodium oxybate oral solution) 7,765,107
Par Pharm., Inc. v. Jazz Pharms., Inc., IPR2015-00548 (PTAB) Jan. 8, 2015 N/A Xyrem® (sodium oxybate oral solution) 7,895,059
Teva Pharms. USA, Inc. v. ViiV Healthcare Co., IPR2015-00550 (PTAB) Jan. 8, 2015 N/A Trizivir® (abacavir sulfate / lamivudine / zidovudine) 6,417,191
Par Pharm., Inc. v. Jazz Pharms., Inc., IPR2015-00551 (PTAB) Jan. 8, 2015 N/A Xyrem® (sodium oxybate oral solution) 8,457,988
Amneal Pharms. LLC v. Jazz Pharms., Inc., IPR2015-00554 (PTAB) Jan. 8, 2015 N/A Xyrem® (sodium oxybate oral solution) 7,668,730
Jazz Pharms., Inc. v. Ranbaxy Labs. Ltd., 15-0187 (D.N.J.) Jan. 9, 2015 Hon. Esther Salas Xyrem® (sodium oxybate oral solution) 8,859,619
Pfizer Inc. v. Mylan Inc., 15-0004 (N.D.W.V.) Jan. 9, 2015 Hon. Irene M. Keeley Tygacil® (tigecycline injectable IV infusion)
7,879,828
8,372,995
Horizon Pharma Ireland Ltd. v. Paddock Labs., LLC, 15-0368 (D.N.J.) Jan. 13, 2015 Hon. Noel L. Hillman Pennsaid® (diclofenac sodium topical solution)
8,217,078 
8,252,838
8,546,450
8,563,613
8,618,164
8,871,809
Johnson Matthey Inc. v. Pfizer, Inc., 15-0014 (E.D. Va.) Jan. 13, 2015 Hon. Arenda L. Wright Allen Tikosyn® (dofetilide capsules) 6,124,363
Actelion Pharms Ltd. v. Icos Corp., IPR2015-00561 (PTAB) Jan. 13, 2015 N/A Cialis® (tadalafil tablets) 7,182,958
Actelion Pharms Ltd. v. Icos Corp., IPR2015-00562 (PTAB) Jan. 13, 2015 N/A Cialis® (tadalafil tablets) 6,821,975
Millennium Pharms., Inc. v. Hetero Labs Ltd., 15-0039 (D. Del.) Jan. 14, 2015 Hon. Gregory M. Sleet Velcade® (bortezomib for injection)
6,713,446
6,958,319
Millennium Pharms., Inc. v. Onco Therapies Ltd., 15-0040 (D. Del.) Jan. 14, 2015 Hon. Gregory M. Sleet Velcade® (bortezomib for injection)
6,713,446
6,958,319
Horizon Pharma Ireland Ltd. v. Paddock Labs., LLC, 15-0043 (D. Del.) Jan. 14, 2015 Hon. Sue L. Robinson Pennsaid® (diclofenac sodium topical solution)
8,217,078
8,252,838
8,546,450
8,563,613
8,618,164
8,871,809
Sumitomo Dainippon Pharma Co., Ltd. v. Emcure Pharms. Ltd., 15-0280 (D.N.J.) Jan. 14, 2015 Hon. Stanley R. Chesler Latuda® (lurasidone hydrochloride tablets) 5,532,372
Sumitomo Dainippon Pharma Co., Ltd. v. Invagen Pharms., Inc., 15-0281 (D.N.J.) Jan. 14, 2015 Hon. Stanley R. Chesler Latuda® (lurasidone hydrochloride tablets) 5,532,372
Alcon Labs., Inc. v. Akorn, Inc., 15-0285 (D.N.J.) Jan. 14, 2015 Hon. Madeline C. Arleo Durezol® (difluprednate ophthalmic emulsion) 6,114,319
Sanofi-Aventis U.S. LLC v. Apotex Corp., 15-0287 (D.N.J.) Jan. 14, 2015 Hon. Michael A. Shipp Jevtana® Kit (cabazitaxel injection)
5,847,170
7,241,907
Sanofi-Aventis U.S. LLC v. Breckenridge Pharm., Inc., 15-0289 (D.N.J.) Jan. 14, 2015 Hon. Michael A. Shipp Jevtana® Kit (cabazitaxel injection)
5,847,170
7,241,907
Sanofi-Aventis U.S. LLC v. Onco Therapies Ltd., 15-0290 (D.N.J.) Jan. 14, 2015 Hon. Michael A. Shipp Jevtana® Kit (cabazitaxel injection)
5,847,170
7,241,907
Sanofi-Aventis U.S. LLC v. Apotex Corp., 15-0044 (D. Del.) Jan. 15, 2015 Hon. Leonard P. Stark Jevtana® Kit (cabazitaxel injection)
5,847,170
7,241,907
Sanofi-Aventis U.S. LLC v. Breckenridge Pharm., Inc., 15-80056 (S.D. Fla.) Jan. 15, 2015 Hon. Donald M. Middlebrooks Jevtana® Kit (cabazitaxel injection)
5,847,170
7,241,907
Laboratoire HRA Pharma v. Teva Pharms. USA, Inc., 15-0045 (D. Del.) Jan. 16, 2015 Hon. Richard G. Andrews Ella® (ulipristal acetate oral tablets)
8,426,392
8,512,745
8,735,380
Boehringer Ingelheim GmbH & Co. KG v. Teva Pharms. USA, Inc., 15-0048 (D. Del.) Jan. 16, 2015 Hon. Sue L. Robinson Pradaxa® (dabigatran etexilate mesylate capsules) 6,087,380
Shionogi & Co., Ltd. v. Aurobindo Pharma Ltd., 15-0319 (D.N.J.) Jan. 16, 2015 Hon. Michael A. Shipp Doribax® (doripenem for injection) 8,247,402
Supernus Pharms., Inc. v. Par Pharm. Cos., Inc., 15-0326 (D.N.J.) Jan. 16, 2015 Hon. Susan D. Wigenton Trokendi XR® (topiramate extended-release capsules)
8,298,576
8,298,580
8,663,683
8,877,248
Senju Pharm. Co., Ltd. v. Lupin, Ltd., 15-0335 (D.N.J.) Jan. 16, 2015 Hon. Jerome B. Simandle Prolensa® (bromfenac ophthalmic solution)
8,871,813
8,927,606
Senju Pharm. Co., Ltd. v. Apotex Inc., 15-0336 (D.N.J.) Jan. 16, 2015 Hon. Jerome B. Simandle Prolensa® (bromfenac ophthalmic solution)
8,129,431
8,669,290
8,754,131
8,871,813
8,927,606
Senju Pharm. Co., Ltd. v. Paddock Labs., LLC, 15-0337 (D.N.J.) Jan. 16, 2015 Hon. Jerome B. Simandle Prolensa® (bromfenac ophthalmic solution)
8,129,431
8,669,290
8,754,131
8,871,813
8,927,606
Supernus Pharms., Inc. v. TWi Pharms., Inc., 15-0369 (D.N.J.) Jan. 16, 2015 Hon. Renee Marie Bumb Oxtellar XR® (oxcarbazepine extended-release tablets)
7,722,898
7,910,131
8,617,600
8,821,930
Shionogi & Co., Ltd. v. Aurobindo Pharma Ltd., 15-0478 (N.D. Ill.) Jan. 16, 2015 Hon. Robert W. Gettleman Doribax® (doripenem for injection) 8,247,402
Teva Pharms. USA, Inc. v. AstraZeneca Pharms. LP, 15-0050 (D. Del.) Jan. 19, 2015 Hon. Gregory M. Sleet Byetta® (exenatide injection)
7,297,761
7,741,269
Tris Pharma Inc. v. Par Pharm., Inc., 15-0068 (D. Del.) Jan. 21, 2015 Hon. Gregory M. Sleet
Quillivant XR® (methylphenidate hydrochloride
extended-release oral suspension)
8,062,667
8,287,903
8,465,765
8,563,033
8,778,390
Boehringer Ingelheim GmbH & Co. KG v. Mylan Pharms. Inc., 15-0010 (N.D.W.V.) Jan. 21, 2015 Hon. Irene M. Keeley Pradaxa® (dabigatran etexilate mesylate capsules) 6,087,380
Teva Pharms. USA, Inc. v. Dr. Reddy’s Labs., Ltd., 15-0471 (D.N.J.) Jan. 22, 2015 Hon. Claire C. Cecchi Copaxone® (glatiramer acetate for injection) 5,800,808
Teva Pharms. USA, Inc. v. Synthon Pharms., Inc., 15-0472 (D.N.J.) Jan. 22, 2015 Hon. Claire C. Cecchi Copaxone® (glatiramer acetate for injection) 5,800,808
Acorda Therapeutics, Inc. v. Actavis Labs. FL, Inc., 15-0077 (D. Del.) Jan. 23, 2015 Hon. Leonard P. Stark Ampyra® (dalfampridine extended-release tablets) 5,540,938
Novartis Pharms. Corp. v. Par Pharm., Inc., 15-0078 (D. Del.) Jan. 23, 2015 Hon. Richard G. Andrews Afinitor® (everolimus tablets)
5,665,772
7,297,703
7,741,338
Pfizer Inc. v. Mylan Pharms. Inc., 15-0079 (D. Del.) Jan. 23, 2015 Hon. Gregory M. Sleet Toviaz® (fesoterodine fumarate extended-release tablets)
6,858,650
7,384,980
7,855,230
7,985,772
8,338,478
Astellas Pharma Inc. v. Fresenius Kabi USA, LLC, 15-0080 (D. Del.) Jan. 23, 2015 Hon. Leonard P. Stark Mycamine® (micafungin sodium for injection)
6,107,458
6,774,104
Eli Lilly and Co. v. Fresenius Kabi USA, LLC, 15-0096 (S.D. Ind.) Jan. 23, 2015 Hon. Tanya Walton Pratt Alimta® (pemetrexed disodium for intravenous infusion) 7,772,209
Spectrum Pharms., Inc. v. Amneal Pharms. LLC, 15-0139 (D. Nev.) Jan. 23, 2015 Hon. James C. Mahan Fusilev® (levoleucovorin calcium for injection) 6,500,829
Senju Pharm. Co., Ltd. v. Paddock Labs., LLC, 15-0087 (D. Del.) Jan. 26, 2015 Hon. Sue L. Robinson Prolensa® (bromfenac ophthalmic solution)
8,129,431
8,669,290
8,754,131
8,871,813
8,927,606
AstraZeneca Pharms. LP v. Glenmark Pharms. Ltd., 15-0615 (D.N.J.) Jan. 26, 2015 Hon. Renee Marie Bumb Faslodex® (fulvestrant injection)
6,774,122 
7,456,160
8,329,680
8,466,139
Pfizer Inc. v. Mylan Pharms. Inc., 15-0013 (N.D.W.V.) Jan. 27, 2015 Hon. Irene M. Keeley Toviaz® (fesoterodine fumarate extended-release tablets)
6,858,650
7,384,980 
7,855,230 
7,985,772 
8,338,478
Otsuka Pharm. Co., Ltd. v. Apotex Inc., 15-0109 (D. Del.) Jan. 29, 2015 Hon. Richard G. Andrews Samsca® (tolvaptan tablets)
5,753,677
8,501,730
Bayer Healthcare LLC v. Mylan Pharms. Inc., 15-0114 (D. Del.) Jan. 30, 2015 Hon. Leonard P. Stark Nexavar® (sorafenib tosylate tablets)
8,618,141
8,877,933
Shionogi & Co., Ltd. v. Apotex Corp., 15-0668 (D.N.J.) Jan. 30, 2015 Hon. Peter G. Sheridan Doribax® (doripenem for injection) 8,247,402
Celgene Corp. v. Lannett Holdings, Inc., 15-0697 (D.N.J.) Jan. 30, 2015 Hon. Susan D. Wigenton Thalomid® (thalidomide capsules)
6,045,501
6,315,720
6,561,976
6,561,977
6,755,784
6,869,399
7,141,018
7,230,012
7,435,745
7,874,984
7,959,566
8,204,763
8,315,886
8,589,188
8,626,531
Cosmo Technologies Ltd. v. Par Pharm., Inc., 15-0116 (D. Del.) Feb. 2, 2015 Hon. Leonard P. Stark Uceris® (budesonide tablets)
7,410,651
7,431,943
8,293,273
8,784,888
8,895,064
RE43,799
Cephalon, Inc. v. Unimark Remedies Ltd., 15-0117 (D. Del.) Feb. 2, 2015 Hon. Gregory M. Sleet Nuvigil® (armodafinil tablets) 7,132,570
Sanofi-Aventis U.S. LLC v. Actavis LLC, 15-0776 (D.N.J.) Feb. 2, 2015 Hon. Michael A. Shipp Jevtana® Kit (cabazitaxel injection)
5,847,170 
7,241,907
Teva Pharms. USA, Inc. v. Amneal Pharms. LLC, 15-0124 (D. Del.) Feb. 3, 2015 Hon. Gregory M. Sleet Copaxone® (glatiramer acetate for injection)
8,232,250
8,399,413
Mylan Pharms. Inc. v. Warner-Chilcott Co. LLC, IPR2015-00682 (PTAB) Feb. 3, 2015 N/A
Lo Loestrin® Fe 
(ethinyl estradiol / norethindrone acetate tablets)
7,704,984
Orexo AB v. Actavis Labs. FL, Inc., 15-0826 (D.N.J.) Feb. 4, 2015 Hon. Peter G. Sheridan Abstral® (fentanyl sublingual tablets)
6,759,059 
6,761,910
7,910,132
AstraZeneca AB v. Perrigo Co. PLC, 15-1057 (D.N.J.) Feb. 4, 2015 Hon. Mary L. Cooper
Nexium 24HR® 
(esomeprazole magnesium delayed-release capsules)
6,369,085 
7,411,070
Novartis Pharms. Corp. v. Roxane Labs., Inc., 15-0128 (D. Del.) Feb. 5, 2015 Hon. Richard G. Andrews Afinitor® (everolimus tablets)
5,665,772
7,297,703 
7,741,338
Novartis Pharms. Corp. v. BPI Labs LLC, 15-0950 (D.N.J.) Feb. 5, 2015 Hon. Susan D. Wigenton Zometa® (zoledronic acid for injection) 8,324,189
Jazz Pharms., Inc. v. Amneal Pharms., LLC, 15-1043 (D.N.J.) Feb. 6, 2015 Hon. Esther Salas Xyrem® (sodium oxybate oral solution)
8,731,963
8,772,306
8,859,619
Dr. Reddy’s Labs., Inc. v. Fresenius Kabi USA, LLC, IPR2015-00715 (PTAB) Feb. 6, 2015 N/A Diprivan® (propofol injectable) 8,476,010
Mylan Pharms. Inc. v. Yeda Research & Development Co. Ltd., IPR2015-00644 (PTAB) Feb. 7, 2015 N/A Copaxone® (glatiramer acetate for injection) 8,399,413
Novartis Pharms. Corp. v. BPI Labs, LLC, 15-0272 (M.D. Fla.) Feb. 9, 2015 Hon. Susan C Bucklew Zometa® (zoledronic acid for injection) 8,324,189
Roxane Labs., Inc. v. Lupin Ltd., 15-1095 (D.N.J.) Feb. 10, 2015 Hon. Stanley R. Chesler PhosLo® GelCaps (calcium acetate capsules) 8,563,032
Novartis AG v. Ezra Ventures, LLC, 15-0150 (D. Del.) Feb. 11, 2015 Hon. Leonard P. Stark Gilenya® (fingolimod hydrochloride capsules) 5,604,229
Novartis AG v. HEC Pharm Co., Ltd., 15-0151 (D. Del.) Feb. 11, 2015 Hon. Leonard P. Stark Gilenya® (fingolimod hydrochloride capsules) 5,604,229
Novo Nordisk Inc. v. Sun Pharm. Indus. Ltd., 15-1287 (D.N.J.) Feb. 12, 2015 Hon. Michael A. Shipp Vagifem® (estradiol tablets) 7,018,992
Forest Labs., LLC v. Alembic Pharms. Ltd., 15-0158 (D. Del.) Feb. 13, 2015 Hon. Sue L. Robinson Saphris® (asenapine maleate tablets) 5,763,476
AbbVie, Inc. v. Mylan Pharms. Inc., 15-1402 (N.D. Ill.) Feb. 13, 2015 Hon. Robert W. Gettleman Kaletra® (lopinavir / ritonavir tablets)
8,025,899
8,268,349
8,309,613
8,377,952
8,399,015
8,470,347
8,691,878
Helsinn Healthcare S.A. v. Gavis Pharma LLC, 15-1228 (D.N.J.) Feb. 13, 2015 Hon. Mary L. Cooper Aloxi® (palonosetron hydrochloride IV solution)
7,947,724
7,947,725
7,960,424
8,598,219
8,729,094
Novartis AG v. Ezra Ventures, LLC, 15-0095 (E.D. Ark.) Feb. 13, 2015 Hon. Kristine G. Baker Gilenya® (fingolimod hydrochloride capsules) 5,604,229
Cosmo Technologies Ltd. v. Actavis Labs. FL, Inc., 15-0164 (D. Del.) Feb. 17, 2015 Hon. Leonard P. Stark Uceris® (budesonide tablets)
7,410,651
7,431,943
8,293,273
8,784,888
8,895,064
RE43,799
INO Therapeutics LLC v. Praxair Distribution, Inc., 15-170 (D. Del.) Feb. 19, 2015 Hon. Gregory M. Sleet INOmax® (nitric oxide for inhalation)
8,282,966
8,293,284
8,431,163
8,795,741
8,846,112
8,291,904
8,573,210
8,573,209
8,776,794
8,776,795
Cosmo Technologies Ltd. v. Actavis Labs. FL, Inc., 15-1312 (D.N.J.) Feb. 19, 2015 Hon. Madeline C. Arleo Uceris® (budesonide tablets)
7,410,651
7,431,943
8,293,273
8,784,888
8,895,064
RE43,799
Ferring Pharms. Inc. v. Par Pharm., Inc., 15-0173 (D. Del.) Feb. 20, 2015 Hon. Richard G. Andrews
Prepopik® 
(sodium picosulfate / magnesium oxide / citric acid solution)
8,450,338
8,481,083
Fresenius Medical Care Holdings, Inc. v. Novel Labs., Inc., 15-10472 (D. Mass.) Feb. 20, 2015 Hon. Richard G. Stearns PhosLo® GelCaps (calcium acetate)
6,576,665
6,875,445
Jazz Pharms., Inc. v. Roxane Labs., Inc., 15-1360 (D.N.J.) Feb. 20, 2015 Hon. Esther Salas Xyrem® (sodium oxybate oral solution)
8,461,203
8,772,306
8,859,619
Fresenius Medical Care Holdings, Inc. v. Novel Labs., Inc., 15-1361 (D.N.J.) Feb. 20, 2015 Hon. Peter G. Sheridan PhosLo® GelCaps (calcium acetate)
6,576,665
6,875,445
Cephalon, Inc. v. Sandoz Inc., 15-0178 (D. Del.) Feb. 23, 2015 Hon. Gregory M. Sleet Treanda® (bendamustine hydrochloride for infusion)
8,669,279
8,883,836
8,895,756
Cephalon, Inc. v. Dr. Reddy’s Labs., Ltd., 15-0179 (D. Del.) Feb. 23, 2015 Hon. Gregory M. Sleet Treanda® (bendamustine hydrochloride for infusion)
8,669,279
8,883,836
8,895,756
Shire LLC v. Par Pharm., Inc., 15-1454 (D.N.J.) Feb. 26, 2015 Hon. Renee Marie Bumb

Adderall XR® (dextroamphetamine sulfate / 
dextroamphetamine saccharate / 
amphetamine aspartate monohydrate / 
amphetamine sulfate tablets)
RE42,096
RE41,148
Purdue Pharma L.P. v. Actavis Labs. UT, Inc., 15-0192 (D. Del.) Feb. 27, 2015 Hon. Sue L. Robinson Butrans® (buprenorphine transdermal system)
RE41,408
RE41,489
RE41,571
Cosmo Technologies Ltd. v. Alvogen Pine Brook, Inc., 15-0193 (D. Del.) Feb. 27, 2015 Hon. Leonard P. Stark Uceris® (budesonide tablets)
7,410,651
8,784,888
RE43,799
AstraZeneca Pharms. LP v. Macleods Pharms., Ltd., 15-1513 (D.N.J.) Feb. 27, 2015 Hon. Claire C. Cecchi
Seroquel XR® 
(quetiapine fumarate extended-release tablets)
5,948,437
Coalition for Affordable Drugs (ADROCA) LLC v. Acorda Therapeutics, Inc., IPR2015-00817 (PTAB) Feb. 27, 2015 N/A Ampyra® (dalfampridine extended-release tablets) 8,007,826
Otsuka Pharm. Co., Ltd. v. Amneal Pharms. LLC, 15-1585 (D.N.J.) Mar. 2, 2015 Hon. Jerome B. Simandle Abilify® (aripiprazole tablets)
8,017,615
8,580,796
8,642,760
8,759,350
Mylan Pharms. Inc. v. Yeda Research & Development Co. Ltd., IPR2015-00830 (PTAB) Mar. 3, 2015 N/A
Copaxone® 
(glatiramer acetate for injection)
8,969,302
Vivus, Inc. v. Actavis Labs. FL, Inc., 15-1636 (D.N.J.) Mar. 4, 2015 Hon. Stanley R. Chesler
Qsymia® (phentermine / 
topiramate extended-release capsules)
8,895,057
8,895,058
Novartis AG v. HEC Pharm Co., Ltd., 15-1647 (D.N.J.) Mar. 5, 2015 Hon. Claire C. Cecchi Gilenya® (fingolimod hydrochloride capsules) 5,604,229
Boehringer Ingelheim Pharma GMBH & Co. KG v. Breckenridge Pharm., Inc., 15-1662 (D.N.J.) Mar. 5, 2015 Hon. Mary L. Cooper Pradaxa® (dabigatran etexilate mesylate capsules) 6,087,380
Baxter Healthcare Corp. v. Sagent Pharms. Inc., 15-1684 (D.N.J.) Mar. 6, 2015 Hon. Jerome B. Simandle
Brevibloc® 
(esmolol hydrochloride in sodium chloride solution)
6,310,094
6,528,540
Otsuka Pharm. Co., Ltd. v. Wockhardt Bio AG, 15-1690 (D.N.J.) Mar. 6, 2015 Hon. Jerome B. Simandle Abilify® (aripiprazole tablets)
8,759,350
7,053,092
Biomarin Pharm. Inc. v. Par Pharm., Inc., 15-1706 (D.N.J.) Mar. 6, 2015 Hon. Michael A. Shipp Kuvan® (sapropterin dihydrochloride tablets)
7,566,462
7,566,714
7,612,073
7,727,987
8,003,126
8,067,416
RE43,797
8,318,745
Baxter Healthcare Corp. v. Sagent Pharms. Inc., 15-2076 (N.D. Ill.) Mar. 9, 2015 Hon. Richard A. Posner
Brevibloc® 
(esmolol hydrochloride in sodium chloride solution)
6,310,094
6,528,540
Otsuka Pharm. Co., Ltd. v. Sandoz Inc., 15-1716 (D.N.J.) Mar. 9, 2015 Hon. Jerome B. Simandle Abilify® (aripiprazole tablets)
8,017,615
8,580,796
8,642,760
8,759,350
Allergan Sales, LLC v. Sandoz, Inc., 15-0347 (E.D. Tex.) Mar. 9, 2015 Hon. Rodney Gilstrap
Combigan® (brimonidine tartrate /
timolol maleate ophthalmic solution)
7,030,149
7,320,976
7,642,258
8,748,425
Ferrum Ferro Capital, LLC v. Allergan Sales, LLC, IPR2015-00858 (PTAB) Mar. 9, 2015 N/A
Combigan® 
(brimonidine tartrate / 
timolol maleate ophthalmic solution)
7,030,149
Sanofi-Aventis U.S. LLC v. Apotex Corp., 15-1835 (D.N.J.) Mar. 11, 2015 Hon. Michael A. Shipp Jevtana® Kit (cabazitaxel injection) 8,927,592
Sanofi-Aventis U.S. LLC v. Breckenridge Pharm., Inc., 15-1836 (D.N.J.) Mar. 11, 2015 Hon. Michael A. Shipp Jevtana® Kit (cabazitaxel injection) 8,927,592
Galderma Labs., L.P. v. Actavis Labs. UT, Inc., 15-0232 (D. Del.) Mar. 12, 2015 Hon. Leonard P. Stark Mirvaso® (brimonidine topical gel)
7,439,241
8,410,102
8,426,410
8,859,551
8,513,247
8,513,249
Accord Healthcare Inc. v. Daiichi Sankyo Co., Ltd., IPR2015-00864 (PTAB) Mar. 12, 2015 N/A Effient® (prasugrel hydrochloride tablets) 8,404,703
Accord Healthcare Inc. v. Daiichi Sankyo Co., Ltd., IPR2015-00865 (PTAB) Mar. 13, 2015 N/A Effient® (prasugrel hydrochloride tablets) 8,569,325
Apotex Inc. v. Wyeth LLC, IPR2015-00873 (PTAB) Mar. 12, 2015 N/A Tygacil® (tigecycline injectable IV infusion) 7,879,828
Horizon Pharma Ireland Ltd. v. Taro Pharms. USA, Inc., 15-2046 (D.N.J.) Mar. 13, 2015 Hon. Noel L. Hillman Pennsaid® (diclofenac sodium topical solution)
8,217,078
8,252,838
8,546,450
8,563,613
8,618,164
8,871,809
Praxair Distribution, Inc. v. iNO Therapeutics, LLC, IPR2015-00884 (PTAB) Mar. 16, 2015 N/A INOmax® (nitric oxide) 8,291,904
Praxair Distribution, Inc. v. iNO Therapeutics, LLC, IPR2015-00888 (PTAB) Mar. 16, 2015 N/A INOmax® (nitric oxide) 8,776,794
Praxair Distribution, Inc. v. iNO Therapeutics, LLC, IPR2015-00889 (PTAB) Mar. 16, 2015 N/A INOmax® (nitric oxide) 8,573,209
Praxair Distribution, Inc. v. iNO Therapeutics, LLC, IPR2015-00891 (PTAB) Mar. 16, 2015 N/A INOmax® (nitric oxide) 8,573,210
Praxair Distribution, Inc. v. iNO Therapeutics, LLC, IPR2015-00893 (PTAB) Mar. 16, 2015 N/A INOmax® (nitric oxide) 8,776,795
Bristol-Myers Squibb Co. v. Mylan Pharms., Inc., 15-1949 (D.N.J.) Mar. 17, 2015 Hon. Freda L. Wolfson Reyataz® (atazanavir sulfate capsules) 6,087,383
Otsuka Pharm. Co., Ltd. v. Indoco Remedies Ltd., 15-1967 (D.N.J.) Mar. 17, 2015 Hon. Jerome B. Simandle Abilify® (aripiprazole tablets)
8,017,615
8,580,796
8,642,760
8,759,350
Bristol-Myers Squibb Co. v. Mylan Pharms., Inc., 15-0049 (N.D.W.V.) Mar. 19, 2015 Hon. Irene M. Keeley Reyataz® (atazanavir sulfate capsules) 6,087,383
Innopharma Licensing, Inc. v. Senju Pharm. Co., Ltd., IPR2015-00902 (PTAB) Mar. 19, 2015 N/A Prolensa® (bromfenac ophthalmic solution) 8,669,290
Innopharma Licensing, Inc. v. Senju Pharm. Co., Ltd., IPR2015-00903 (PTAB) Mar. 19, 2015 N/A Prolensa® (bromfenac ophthalmic solution) 8,129,431
Noven Pharms., Inc. v. Actavis Labs. UT, Inc., 15-0249 (D. Del.) Mar. 20, 2015 Hon. Leonard P. Stark Minivelle® (estradiol transdermal system) 8,231,906
Merck Sharp & Dohme Corp. v. Amneal Pharms. LLC, 15-0250 (D. Del.) Mar. 20, 2015 Hon. Sue L. Robinson Nasonex® (mometasone furoate monohydrate metered nasal spray) 6,127,353
Boehringer Ingelheim Pharma GmbH & Co. KG v.
Breckenridge Pharm., Inc., 15-80377 (S.D. Fla.)
Mar. 20, 2015 Hon. Kenneth A. Marra Pradaxa® (dabigatran etexilate mesylate capsules)) 6,087,380
Helsinn Healthcare S.A. v. Hospira, Inc., 15-2077 (D.N.J.) Mar. 23, 2015 Hon. Mary L. Cooper Aloxi® (palonosetron hydrochloride IV solution)
7,947,724
7,947,725
7,960,424
8,598,219
8,729,094
Helsinn Healthcare S.A. v. Par Pharm. Cos., Inc., 15-2078 (D.N.J.) Mar. 23, 2015 Hon. Mary L. Cooper Aloxi® (palonosetron hydrochloride IV solution)
7,947,724
7,947,725
7,960,424
8,598,219
8,729,094
Purdue Pharma L.P. v. Collegium Pharm., Inc., 15-0260 (D. Del.) Mar. 24, 2015 Hon. Sue L. Robinson OxyContin® (oxycodone hydrochloride extended-release tablets)
7,674,799
7,674,800
7,683,072
8,652,497
Helsinn Healthcare S.A. v. Hospira, Inc., 15-0264 (D. Del.) Mar. 25, 2015 Hon. Gregory M. Sleet Aloxi® (palonosetron hydrochloride IV solution)
7,947,724
7,947,725
7,960,424
8,598,219
8,729,094
Helsinn Healthcare S.A. v. Par Pharm. Cos., Inc., 15-0265 (D. Del.) Mar. 25, 2015 Hon. Gregory M. Sleet Aloxi® (palonosetron hydrochloride IV solution)
7,947,724
7,947,725
7,960,424
8,598,219
8,729,094
Purdue Pharma L.P. v. Collegium Pharm., Inc., 15-11294 (D. Mass.) Mar. 26, 2015 Hon. F. Dennis Saylor, IV OxyContin® (oxycodone hydrochloride extended-release tablets)
7,674,799
7,674,800
7,683,072
8,652,497
Reckitt Benckiser LLC v. Amneal Pharms LLC, 15-2155 (D.N.J.) Mar. 26, 2015 Hon. Claire C. Cecchi Mucinex® (guaifenesin extended-release tablets)
6,372,252
6,955,821
7,838,032
Reckitt Benckiser LLC v. Perrigo Co., 15-2156 (D.N.J.) Mar. 26, 2015 Hon. Claire C. Cecchi Mucinex® (guaifenesin extended-release tablets)
6,372,252
6,955,821
7,838,032
Novo Nordisk Inc. v. Baxter Healthcare Corp., 15-2157 (D.N.J.) Mar. 26, 2015 Hon. Peter G. Sheridan Novoeight® (turoctocog alfa)
6,100,061
6,475,725
6,936,441
7,094,574
8,080,414
8,084,251
8,084,252
8,329,465
Forest Labs., LLC v. Accord Healthcare Inc., 15-0272 (D. Del.) Mar. 27, 2015 Hon. Gregory M. Sleet Viibryd® (vilazodone tabletsa)
7,834,020
8,193,195
8,236,804
8,673,921
Forest Labs., LLC v. Alembic Pharms. Ltd., 15-0273 (D. Del.) Mar. 27, 2015 Hon. Gregory M. Sleet Viibryd® (vilazodone tabletsa)
7,834,020
8,193,195
8,236,804
8,673,921
Forest Labs., LLC v. Apotex Inc., 15-0274 (D. Del.) Mar. 27, 2015 Hon. Gregory M. Sleet Viibryd® (vilazodone tabletsa)
7,834,020
8,193,195
8,236,804
8,673,921
Forest Labs., LLC v. Teva Pharms. USA, Inc., 15-0275 (D. Del.) Mar. 27, 2015 Hon. Gregory M. Sleet Viibryd® (vilazodone tabletsa)
7,834,020
8,193,195
8,236,804
8,673,921
McNeil-PPC, Inc. v. Watson Labs., Inc., 15-2197 (D.N.J.) Mar. 27, 2015 Hon. Madeline C. Arleo Rogaine® (5% minoxidil topical aerosol foam) 6,946,120
Forest Labs., LLC v. Invagen Pharms. Inc., 15-0277 (D. Del.) Mar. 30, 2015 Hon. Gregory M. Sleet Viibryd® (vilazodone tabletsa)
7,834,020
8,193,195
8,236,804
8,673,921

The articles on our Website include some of the publications and papers authored by our attorneys, both before and after they joined our firm. The content of these articles should not be taken as legal advice.